| 股號 / 名稱 | 現金及約當現金 | 流動資產 | 總資產 |
| TEVA Teva Pharmaceutical Industries Limited | 120,498,996,696.25 | 453,643,281,680.0 | 1,314,016,008,569.75 |
| BHC Bausch Health Companies Inc. | 81,926,130,448.75 | 244,228,883,044.0 | 840,163,182,437.0 |
| RDY Dr. Reddy's Laboratories Limited | 4,491,638,180.2 | 102,186,485,586.51 | 197,275,290,015.03 |
| 1795 美時 | 6,325,432,000 | 25,659,301,000 | 108,585,630,000 |
| BBIO BridgeBio Pharma, Inc. | 50,552,312,741.77 | 67,407,105,783.62 | 71,270,326,695.49 |
| AMPH Amphastar Pharmaceuticals, Inc. | 7,372,164,882.96 | 20,801,357,719.42 | 57,488,933,918.75 |
| 6472 保瑞 | 8,431,018,000 | 24,395,699,000 | 52,077,131,000 |
| SUPN Supernus, Inc. | 10,055,319,833.75 | 26,374,609,400.0 | 43,913,724,651.0 |
| TSHA Taysha Gene Therapies, Inc. | 15,013,977,178.78 | 15,212,676,892.35 | 15,509,358,279.84 |
| 3705 永信 | 1,681,311,000 | 7,568,539,000 | 13,176,178,000 |
| 1720 生達 | 2,014,373,000 | 5,775,065,000 | 12,315,901,000 |
| 4120 友華 | 1,545,691,000 | 4,035,955,000 | 11,750,301,000 |
| ASMB Assembly Biosciences Inc | 1,064,413,298.86 | 10,812,864,552.24 | 10,906,955,971.28 |
| PSNL Personalis, Inc. | 3,097,961,620.12 | 8,078,938,478.36 | 10,290,548,381.34 |
| 4747 強生* | 261,729,000 | 602,886,000 | 2,558,703,000 |
| 6461 益得 | 95,420,000 | 370,571,000 | 2,295,483,000 |
| SLGL SOL-GEL TECHNOLOGIES LTD. | 549,317,177.28 | 1,684,051,778.45 | 1,772,241,878.63 |
| CPHI China Pharma Holdings Inc | 10,051,033.96 | 66,154,773.39 | 1,474,007,686.02 |
| 6130 上亞科技 | 75,442,000 | 178,444,000 | 735,886,000 |
載入數據中...
最新要聞
和學名藥相關的產業概念股
學名藥概念股相關指標排名
學名藥每月營收
學名藥每股盈餘
學名藥每股淨值
學名藥損益表
學名藥總資產
學名藥負債和股東權益
學名藥現金流量表
學名藥利潤比率
學名藥營業費用率拆解
學名藥杜邦分析
學名藥ROE / ROA
學名藥經營週轉能力
學名藥營運週轉天數
學名藥現金股利發放率
學名藥財務結構比率
學名藥流速動比率
學名藥利息保障倍數
學名藥現金流量分析
學名藥營業現金流對淨利比
學名藥盈餘再投資比率
學名藥月營收成長率
學名藥營收成長率
學名藥毛利成長率
學名藥營業利益成長率
學名藥稅後淨利成長率
學名藥每股盈餘成長率
學名藥本益比評價
學名藥股價淨值比評價
學名藥現金股利殖利率
學名藥平均現金股息殖利率
學名藥董監持股比例
學名藥董監持股質押比例